Filing Details
- Accession Number:
- 0001181431-13-033603
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-07 17:04:48
- Reporting Period:
- 2013-06-05
- Filing Date:
- 2013-06-07
- Accepted Time:
- 2013-06-07 17:04:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1466301 | Clovis Oncology Inc. | CLVS | Pharmaceutical Preparations (2834) | 900475355 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1374539 | R Andrew Allen | C/O Clovis Oncology, Inc. 2525 28Th Street, Suite 100 Boulder CO 80301 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-06-05 | 700 | $65.77 | 21,894 | No | 4 | S | Indirect | By wife |
Common Stock | Disposition | 2013-06-05 | 4,500 | $66.89 | 17,394 | No | 4 | S | Indirect | By wife |
Common Stock | Disposition | 2013-06-05 | 6,494 | $67.65 | 10,900 | No | 4 | S | Indirect | By wife |
Common Stock | Disposition | 2013-06-05 | 2,500 | $68.84 | 8,400 | No | 4 | S | Indirect | By wife |
Common Stock | Disposition | 2013-06-05 | 5,800 | $70.06 | 2,600 | No | 4 | S | Indirect | By wife |
Common Stock | Disposition | 2013-06-05 | 2,600 | $70.72 | 0 | No | 4 | S | Indirect | By wife |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By wife |
No | 4 | S | Indirect | By wife |
No | 4 | S | Indirect | By wife |
No | 4 | S | Indirect | By wife |
No | 4 | S | Indirect | By wife |
No | 4 | S | Indirect | By wife |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 181,919 | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.28 to $66.18, inclusive. The reporting person undertakes to provide to Clovis Oncology, Inc., any security holder of Clovis Oncology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5) and (6) to this Form 4.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.33 to $67.32, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.36 to $68.20, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.39 to $69.37, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.48 to $70.46, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.49 to $71.11, inclusive.
- Represents shares owned directly by the reporting person.